1. Whole Tumor Histogram Analysis Using DW MRI in Primary Central Nervous System Lymphoma Correlates with Tumor Biomarkers and Outcome
   null Chong et al, 2019, Cancers CrossRef
2. GCB-type is a favorable prognostic factor in primary CNS diffuse large B-cell lymphomas
   Chelsea Marcus et al, 2021, Journal of Clinical Neuroscience CrossRef
3. Primary central nervous system lymphoma in China: a single-center retrospective analysis of 167 cases
   Xiang-Gui Yuan et al, 2020, Annals of Hematology CrossRef
4. Diffusion-weighted MR imaging histogram analysis in HIV positive and negative patients with primary central nervous system lymphoma as a predictor of outcome and tumor proliferation
   Bilal Khan et al, 2020, Oncotarget CrossRef
5. The Correlation Between Apparent Diffusion Coefficient (ADC) and Relative Cerebral Blood Volume (rCBV) with Ki-67 Expression in Central Nervous System Lymphoma
   Nguyen Duy Hung et al, 2020, International Journal of Cancer Management CrossRef
6. Primary central nervous system lymphoma: clinicopathological and genomic insights for therapeutic development
   Kensuke Tateishi et al, 2021, Brain Tumor Pathology CrossRef
7. Molecular Update and Evolving Classification of Large B-Cell Lymphoma
   Arantza Onaindia et al, 2021, Cancers CrossRef
8. Clinical Impact of the Histopathological Index and Neuroimaging Features Status in Primary Central Nervous System Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Analysis of 51 Cases
   Zhou Qi et al, 2022, Frontiers in Oncology CrossRef
9. Clinical Outcomes of RTOG 9310 Protocol for Primary Central Nervous System Lymphoma: Single-Center Experience with 87 Patients
   Jinuk Kim et al, 2021, Current Oncology CrossRef
10. Sentinel lesion and significance of rebiopsy: a case of primary CNS lymphoma
    Dominik Drobisz et al, 2022, Neurologie pro praxi CrossRef
11. Extranodal lymphoma: pathogenesis, diagnosis and treatment
    Hua Yang et al, 2023, Molecular Biomedicine CrossRef
12. Analysis of Cellular Heterogeneity in Immune Microenvironment of Primary Central Nervous System Lymphoma by Single-Cell Sequencing
    Boyuan Wei et al, 2021, Frontiers in Oncology CrossRef
13. Primary extranodal diffuse large B‐cell lymphoma: Molecular features, treatment, and prognosis
    Si‐Yuan Chen et al, 2022, Aging and Cancer CrossRef
14. Bruton’s tyrosine kinase inhibitors in the treatment of primary central nervous system lymphoma: A mini-review
    Jing Shen et al, 2022, Frontiers in Oncology CrossRef
15. Update on Novel Therapeutics for Primary CNS Lymphoma
    Lauren R. Schaff et al, 2021, Cancers CrossRef
16. Prognostic significance of immunohistochemical markers in Primary CNS lymphomas
    Indu Ramachandran Nair et al, 2021, IP Archives of Cytology and Histopathology Research CrossRef
17. Primary Central Nervous System Lymphomas: A Diagnostic Overview of Key Histomorphologic, Immunophenotypic, and Genetic Features
    Marietya I. S. Lauw et al, 2020, Diagnostics CrossRef